STOCK TITAN

PREDICTMEDIX AI INC - PMEDF STOCK NEWS

Welcome to our dedicated page for PREDICTMEDIX AI news (Ticker: PMEDF), a resource for investors and traders seeking the latest updates and insights on PREDICTMEDIX AI stock.

Predictmedix AI Inc. (PMEDF) is a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI). The company recently announced a partnership with KGK Science, a renowned name in clinical research, to advance health research and product development. This collaboration aims to introduce transformative changes in healthcare innovation, particularly in clinical trial efficiency and health product development. By leveraging Predictmedix AI's cutting-edge technologies and KGK Science's expertise, the partnership is set to redefine health assessment methodologies and outcomes.

KGK Science, with over 22 years of experience, is known for its expertise in clinical research and regulatory support for nutraceutical, cannabis, and hemp industries. On the other hand, Predictmedix AI's Safe Entry Stations utilize multispectral cameras to predict a variety of health issues, including vital parameters, drug impairment, fatigue, and mental illnesses. Together, these companies are focused on enhancing health research and product development through innovative technologies and creating impactful advancements in healthcare solutions.

Rhea-AI Summary

Predictmedix Inc. (CSE:PMED)(OTCQB:PMEDF) announces a strategic partnership with MZ Group to enhance its investor relations and financial communications. This collaboration aims to boost the company's visibility in capital markets and promote its AI-driven health screening solutions that detect various health issues, including COVID-19 and substance impairments. Notable clients include Indian Oil, which employs over 33,000 individuals. MZ Group, known for its extensive network, will support Predictmedix in achieving profitability and expanding its market presence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.71%
Tags
none
-
Rhea-AI Summary

Predictmedix Inc. (OTCQB: PMEDF) has filed a registration statement on Form 20-F with the SEC, aiming to register its common shares. This step will enable the Company to operate as a reporting issuer under U.S. securities laws. Predictmedix focuses on developing AI technologies for health and safety, including real-time screening for COVID-19 symptoms, alcohol impairment, and mental health conditions. This move broadens its potential market presence in the U.S.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.61%
Tags
none
-
Rhea-AI Summary

Predictmedix Inc. (CSE:PMED) has expanded its SAFE ENTRY program through a partnership with SBL Testing Technologies Inc. This collaboration targets North America and the Caribbean, utilizing Predictmedix's AI-powered screening technology to identify infectious disease symptoms and impairments from THC and alcohol.

The SAFE ENTRY Stations offer autonomous, non-invasive screening, with a patent pending in North America. The partnership is positioned to enhance workplace safety amidst the ongoing COVID-19 pandemic and future public health challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
partnership
Rhea-AI Summary

Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) is deploying Safe Entry Stations at the Lavazza Drive-In Film Festival in Ontario from June 27 to July 17, 2021. This initiative aims to enhance safety by screening staff and attendees for infectious diseases, including COVID-19, using a rapid AI algorithm. This deployment signifies Predictmedix's expansion into the event industry, following previous implementations at the Super Bowl and HockeyFest. The festival seeks to reconnect communities through a diverse film program, welcoming over 20,000 attendees last year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.75%
Tags
none
-
Rhea-AI Summary

Predictmedix Inc. (OTCQB: PMEDF) announces the deployment of its Safe Entry Station units at HockeyFest 2021, North America's largest street and pond hockey festival, starting June 25 in London, Ontario. The partnership with Juiceworks Exhibits and Jones Entertainment Group aims to enhance participant safety through AI-powered screenings for COVID-19 symptoms at events in nine cities. The deployment marks Predictmedix's second venture in live events, highlighting its commitment to provide innovative health solutions to ensure player and spectator safety amid the pandemic.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.14%
Tags
partnership
-
Rhea-AI Summary

Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) has launched Safe Entry Stations at Aster Garden Optima Living Community, marking its entry into the North American assisted living market. These AI-powered stations are intended to enhance safety for residents, particularly amid COVID-19. Aster Gardens, which opened on March 21, 2021, aims to provide a secure environment for elderly residents. This initiative involves partnerships with Optima Living, Connectus Global, and Juiceworks Exhibits, showcasing a commitment to leveraging technology in healthcare and community safety.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.25%
Tags
partnership
Rhea-AI Summary

Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) has deployed Safe Entry Stations at four office towers in Calgary and Edmonton, marking a significant move in partnership with Aspen Properties and Juiceworks. This 24-month contract allows for voluntary, AI-driven screening of infectious disease symptoms, including COVID-19, using non-invasive technology. The initiative aims to enhance safety in shared spaces, showcasing Predictmedix's advanced AI capabilities and providing visibility in the commercial real estate sector. The partnership highlights a proactive approach to tenant safety during ongoing health challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.07%
Tags
partnership
-
Rhea-AI Summary

Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) has secured a 24-month contract to implement Safe Entry Stations within Flow Water Inc.'s operations in North America. Following a successful pilot test, this expansion will enhance health and safety protocols across Flow's facilities, significantly reducing absenteeism and improving employee security. The AI-driven technology, designed by infectious disease experts, quickly screens for COVID-19 symptoms, reinforcing Predictmedix's commitment to innovative health solutions amidst ongoing pandemic challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.94%
Tags
none
-
Rhea-AI Summary

Predictmedix Inc. (CSE:PMED) (OTCQB:PMEDF) has announced a partnership with JUICEWORKS EXHIBITS and CONNECTUS Global to deploy Safe Entry Stations, utilizing AI technology for assessing symptoms associated with infectious diseases like COVID-19. This innovative technology is designed to enhance safety in shared spaces, contributing to a return to normalcy in the community. The customizable Safe Entry Stations can be implemented in various settings, reflecting a significant advancement in health screening.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
partnership
Rhea-AI Summary

Predictmedix has appointed Kingswood Capital Markets to facilitate its potential NASDAQ listing under the symbol PMEDF. This move aims to enhance liquidity and capital market exposure. The listing application is subject to various regulatory requirements, including market maker retention and SEC registration. While this uplisting could significantly support Predictmedix's AI healthcare initiatives, there is no guarantee of NASDAQ acceptance. The company is dedicated to developing non-invasive AI tools for detecting impairment and screening for infectious diseases.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.4%
Tags
none

FAQ

What is the current stock price of PREDICTMEDIX AI (PMEDF)?

The current stock price of PREDICTMEDIX AI (PMEDF) is $0.0095 as of October 14, 2024.

What is the market cap of PREDICTMEDIX AI (PMEDF)?

The market cap of PREDICTMEDIX AI (PMEDF) is approximately 1.8M.

What is Predictmedix AI Inc. known for?

Predictmedix AI Inc. is a leading provider of rapid health screening solutions powered by proprietary artificial intelligence (AI).

Who is KGK Science and what expertise do they bring to the partnership?

KGK Science is a respected name in clinical research and regulatory consulting, offering top-tier expertise in nutraceutical, cannabis, and hemp industries.

What are the key focus areas of the partnership between Predictmedix AI Inc. and KGK Science?

The partnership aims to introduce transformative changes in healthcare innovation, particularly in clinical trial efficiency and health product development.

How do Predictmedix AI's Safe Entry Stations contribute to the partnership?

Predictmedix AI's Safe Entry Stations utilize multispectral cameras to predict various health issues, including vital parameters, drug impairment, fatigue, and mental illnesses, enhancing health research and product development.

What are the expected outcomes of the collaboration between Predictmedix AI Inc. and KGK Science?

The collaboration is set to redefine health assessment methodologies and outcomes, offering impactful advancements in healthcare solutions.

PREDICTMEDIX AI INC

OTC:PMEDF

PMEDF Rankings

PMEDF Stock Data

1.80M
125.63M
16.54%
Medical Devices
Healthcare
Link
United States of America
Toronto